TG101348/TG-101348/

 Home / Products / Others / TG101348/TG-101348/
TG101348/TG-101348/

TG101348/TG-101348/

Cat.No.ABP000705 Chemical NameTG101348/TG-101348/ CAS936091-26-8 MolFormulaC27H36N6O3S MolWeight524.678 Purity >98%

Chemical Name : TG101348/TG-101348/

CAS : 936091-26-8

Synonyms: N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide

Storage:at -20℃ 2 years

Biologieal

We report that TG101348, a selective small-molecule inhibitor of JAK2 with an in vitro IC50 of approximately 3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation. In treated animals, there was a statistically significant reduction in hematocrit and leukocyte count, a dose-dependent reduction/elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis. There were no apparent toxicities and no effect on T cell number. In vivo responses were correlated with surrogate endpoints, including reduction/elimination of JAK2V617F disease burden assessed by quantitative genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.
Enquiry